Signal enhancement ratio of multi-phase contrast-enhanced MRI: an imaging biomarker for survival in pancreatic adenocarcinoma.
Xia C, Qu JR, Jiao YP, Lu CQ, Zhao B, Ge RJ, Qiu Y, Cao BY, Yu Q, Xia TY, Meng XP, Song Y, Zhang LH, Long XY, Ye J, Ding ZM, Cai W, Ju SH.
Xia C, et al. Among authors: zhang lh.
Eur Radiol. 2024 May 15. doi: 10.1007/s00330-024-10746-z. Online ahead of print.
Eur Radiol. 2024.
PMID: 38750169